Neurocognitive impairment in patients randomized to second-line lopinavir/ritonavir-based antiretroviral therapy vs. lopinavir/ritonavir monotherapy

Autor: Bunupuradah, T, Chetchotisakd, P, Jirajariyavej, S, Valcour, V, Bowonwattanuwong, C, Munsakul, W, Klinbuayaem, V, Prasithsirikul, W, Sophonphan, J, Mahanontharit, A, Hirschel, B, Bhakeecheep, S, Ruxrungtham, K, Ananworanich, J, HIV STAR Study Group

Publikováno v: Journal of neurovirology, vol 18, iss 6
Bunupuradah, T; Chetchotisakd, P; Jirajariyavej, S; Valcour, V; Bowonwattanuwong, C; Munsakul, W; et al.(2012). Neurocognitive impairment in patients randomized to second-line lopinavir/ritonavir-based antiretroviral therapy vs. lopinavir/ritonavir monotherapy.. Journal of neurovirology, 18(6), 479-487. doi: 10.1007/s13365-012-0127-9. UC San Francisco: Retrieved from: http://www.escholarship.org/uc/item/1pf2h4ht

We compared rates of neurocognitive impairment (NCI) among 93 Thai adults failing non-nucleoside reverse transcriptase inhibitor (NNRTI)-based combination antiretroviral therapy (cART) before and after switching to lopinavir/ritonavir monotherapy (mL

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::85812a26171bb340788c01f0c030c159
https://escholarship.org/uc/item/1pf2h4ht

Implementation and assessment of a prevention with positives intervention among people living with HIV at five hospitals in Thailand.

Autor: Baipluthong B; Division of Global HIV and TB, U.S. Centers for Disease Control and Prevention, Nonthaburi, Thailand., Anekthananon T; Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand., Munsakul W; Faculty of Medicine, Vajira Hospital, Navamindharadhiraj University, Bangkok, Thailand., Jirajariyavej S; HIV Clinic, Taksin Hospital, Bangkok, Thailand., Asavapiriyanont S; Obstetrics and Gynecology Unit, Rajavithi Hospital, Bangkok, Thailand., Hancharoenkit U; HIV Clinic, Wiang Pa Pao Hospital, Chiang Rai, Thailand., Roongpisuthipong A; Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand., Pattanasin S; Division of Global HIV and TB, U.S. Centers for Disease Control and Prevention, Nonthaburi, Thailand., Martin M; Division of Global HIV and TB, U.S. Centers for Disease Control and Prevention, Nonthaburi, Thailand., Guntamala L; Bureau of AIDS, TB and STIs, Department of Disease Control, Thailand Ministry of Public Health, Nonthaburi, Thailand., Lolekha R; Division of Global HIV and TB, U.S. Centers for Disease Control and Prevention, Nonthaburi, Thailand.

Publikováno v: PloS one [PLoS One] 2017 Feb 03; Vol. 12 (2), pp. e0170558. Date of Electronic Publication: 2017 Feb 03 (Print Publication: 2017).

Low-dose versus standard-dose ritonavir-boosted atazanavir in virologically suppressed Thai adults with HIV (LASA): a randomised, open-label, non-inferiority trial.

Autor: Bunupuradah T; HIV Netherlands Australia Thailand Research Collaboration, The Thai Red Cross AIDS Research Centre, Pathum Wan, Bangkok, Thailand., Kiertiburanakul S; Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand., Avihingsanon A; HIV Netherlands Australia Thailand Research Collaboration, The Thai Red Cross AIDS Research Centre, Pathum Wan, Bangkok, Thailand., Chetchotisakd P; Khon Kaen University, Khon Kaen, Thailand., Techapornroong M; Prapokklao Hospital, Amphur Muang, Chanthaburi, Thailand., Leerattanapetch N; Khon Kaen Hospital, Mueang Khon Kaen, Khon Kaen, Thailand., Kantipong P; Chiangrai Prachanukroh Hospital, Chiang Rai, Thailand., Bowonwatanuwong C; Chonburi Hospital, Baan Suan Muang, Chonburi, Thailand., Banchongkit S; Rayong Hospital, Mueang Rayong, Rayong, Thailand., Klinbuayaem V; Sanpatong Hospital, San Pa Tong, Chiang Mai, Thailand., Mekviwattanawong S; Pranangklao Hospital, Nonthaburi, Thailand., Nimitvilai S; Nakhon Phatom Hospital, Mueang Nakhon Pathom, Nakhon Phatom, Thailand., Jirajariyavej S; Taksin Hospital, Khlong San, Bangkok, Thailand., Prasithsirikul W; Bamrasnaradura Infectious Disease Institute, Mueang Nonthaburi, Nonthaburi, Thailand., Munsakul W; Faculty of Medicine, Vajira Hospital, University of Bangkok Metropolitan Administration, Wachira Phayaban, Dusit, Bangkok, Thailand., Bhakeecheep S; The National Health Security Office, Nonthaburi, Thailand., Chaivooth S; The National Health Security Office, Nonthaburi, Thailand., Phanuphak P; HIV Netherlands Australia Thailand Research Collaboration, The Thai Red Cross AIDS Research Centre, Pathum Wan, Bangkok, Thailand., Cooper DA; Kirby Institute for Infection and Immunity in Society, University of New South Wales, Sydney, NSW, Australia., Apornpong T; HIV Netherlands Australia Thailand Research Collaboration, The Thai Red Cross AIDS Research Centre, Pathum Wan, Bangkok, Thailand., Kerr SJ; HIV Netherlands Australia Thailand Research Collaboration, The Thai Red Cross AIDS Research Centre, Pathum Wan, Bangkok, Thailand; Kirby Institute for Infection and Immunity in Society, University of New South Wales, Sydney, NSW, Australia; Department of Global Health, Academic Medical Center, University of Amsterdam, Amsterdam Institute for Global Health and Development, Amsterdam, Netherlands., Emery S; Kirby Institute for Infection and Immunity in Society, University of New South Wales, Sydney, NSW, Australia., Ruxrungtham K; HIV Netherlands Australia Thailand Research Collaboration, The Thai Red Cross AIDS Research Centre, Pathum Wan, Bangkok, Thailand; Department of Medicine, Faculty of Medicine, Chulalongkorn University, Pathum Wan, Bangkok, Thailand. Electronic address: kiat.r@chula.ac.th.

Publikováno v: The lancet. HIV [Lancet HIV] 2016 Aug; Vol. 3 (8), pp. e343-e350. Date of Electronic Publication: 2016 May 24.

Health facility-based interventions and the uptake of contraception among people living with HIV: A systematic review & meta-analysis.

Autor: R., Revathy¹, Chaurasia, Himanshu¹, Shetty, Siddesh¹, Joshi, Beena¹ bjoshithane@gmail.com

Publikováno v: Indian Journal of Medical Research. Nov/Dec2023, Vol. 158 Issue 5/6, p483-493. 18p.

HIV-1 genital shedding in HIV-infected patients randomized to second-line lopinavir/ritonavir monotherapy versus tenofovir/lamivudine/lopinavir/ritonavir.

Autor: Bunupuradah T; HIV-NAT, the Thai Red Cross AIDS Research Centre, Bangkok, Thailand. torsak.b@hivnat.org., Bowonwattanuwong C, Jirajariyavej S, Munsakul W, Klinbuayaem V, Sophonphan J, Mahanontharit A, Hirschel B, Ruxrungtham K, Ananworanich J

Publikováno v: Antiviral therapy [Antivir Ther] 2014; Vol. 19 (6), pp. 579-86. Date of Electronic Publication: 2014 Jan 24.